Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study.
第一单位:
Hospital Federal dos Servidores do Estado, Rua Sacadura Cabral, 178, Saúde, Rio de Janeiro, RJ, 20221-903, Brazil. cassia.r.g.leal@gmail.com.;Universidade Federal Fluminense, Niterói, Brazil. cassia.r.g.leal@gmail.com.
作者:
医学主题词
老年人(Aged);抗肿瘤药(Antineoplastic Agents);癌, 肝细胞(Carcinoma, Hepatocellular);女(雌)性(Female);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);蛋白激酶抑制剂(Protein Kinase Inhibitors);存活率分析(Survival Analysis);甲胎蛋白类(alpha-Fetoproteins)
DOI
10.1007/s10637-018-0621-x
PMID
29948358
发布时间
2019-06-03
- 浏览8
Investigational new drugs
911-918页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



